Acepodia, Inc. (TPEX:6976)
Taiwan · Delayed Price · Currency is TWD 12.30
+0.20 (1.65%)
Apr 17, 2026, 1:38 PM CST
Acepodia Market Cap
Acepodia has a market cap or net worth of 7.25 billion as of April 17, 2026. Its market cap has decreased by -35.70% in one year.
Market Cap
7.25B
Enterprise Value
3.71B
Revenue
185.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
12.30
Market Cap Chart
Since August 8, 2023, Acepodia's market cap has decreased from 22.92B to 7.25B, a decrease of -68.38%. That is a compound annual growth rate of -34.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 7.25B | -18.88% |
| Dec 31, 2025 | 8.94B | -10.43% |
| Dec 31, 2024 | 9.98B | -48.47% |
| Dec 29, 2023 | 19.36B | -15.54% |
| Aug 8, 2023 | 22.92B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Locus Cell | 9.75B |
| PharmaEngine | 8.46B |
| Gongwin Biopharm Holdings | 8.34B |
| Adimmune | 7.88B |
| TaiGen Biopharmaceuticals Holdings | 7.76B |
| Mycenax Biotech | 6.29B |
| Savior Lifetec | 6.18B |
| Sinphar Pharmaceutical | 6.11B |